PRECISION MEDICINE AND THE FUTURE OF GENOMICS SUMMIT
قمة الطب الدقيق ومستقبل علوم الجينوم

---

PMFG SUMMIT 2026
December 7–9, 2026

PROGRAM AT A GLANCE

Precision Medicine & The Future of Genomics (PMFG) Summit 2026

Core Summit Pillars

The 3-day program is structured around four major scientific and strategic themes:

• Theme A | Next-Gen Therapeutics: Advanced gene/epigenetic editing, novel RNA modalities, and scaling biological manufacturing.
• Theme B | Data Dominance: Federated learning architectures, AI-driven target discovery, and biobanking cybersecurity.
• Theme C | Ecosystem Architects: Fast-track clinical approval frameworks for cell/gene therapies and regulatory parameters for autonomous AI diagnostics.
• Theme D | Clinical Implementation: Sustainable reimbursement models, provider-payer alignment, and bedside pharmacogenomics workflows.

Please Note: All program sessions, topics, formats, timings, and speakers are tentative and subject to change or adjustment prior to the event.

Day 1: Patient Architectures, Next-Gen Therapeutics & Data Sovereignty

Day 1 sets a compelling narrative stage, moving from real-world patient breakthroughs to the massive, secure computational engines driving global target discovery.

Time & Session	Strategic Focus	Featured Highlights & Local Anchors
08:30 – 09:00 Opening Ceremony	Setting the summit’s strategic vision and collaborative clinical goals.	Welcome Address & Institutional Remarks by executive leadership from Sidra Medicine and the Qatar Precision Health Institute (QPHI).
09:00 – 10:30 Opening Keynote & Panel	Patient Advocacy & Co-Creation	Keynote 1: The Patient Architect, detailing patient-led orchestration to break diagnostic odysseys. Keynote 2: Outlines clinical co-management methodologies for families. The Opening Panel: Overcoming friction points between traditional clinical workflows and data-empowered patient advocates, featuring Public Health Policy Representatives.
THE FOCUS Embracing the Promise of Precision Medicine. Utilizing algorithmics, deep-phenotyping, and patient-led orchestration to break diagnostic odysseys. Bridging the gap between big data and patient care, examine the collaborative models driving precision medicine. The session focuses on the methodology required for families and medical teams to co-architect clinical management strategies using comprehensive multi-omic profiles.
10:30 – 11:15	Morning Networking & Coffee Break	Exhibition Hall / Poster Viewings & Technical Showcases
11:15 – 12:30 Theme A	Next-Gen Modalities & Therapeutic Moonshots	Topic: The operational reality of N-of-1 Therapeutic Journeys from molecular diagnosis to clinical reality. Topic: Novel RNA target discoveries and epigenetic modalities for complex neurodevelopmental disorders. Cross-Sector Panel: Structuring regional funding models for high-cost individual cures, anchoring commercial viability with regional investment frameworks.
THE FOCUS Using deep phenotyping and patient-led orchestration to break diagnostic odysseys. Bridging complex multi-omics with actionable, family-centric clinical management. Moving custom, N-of-1 genetic therapies from bench to bedside. Resolving the commercial bottlenecks, funding gaps, and manufacturing scale-up challenges of curative biology.
12:30 – 14:00	Lunch & Networking Break	Main Dining Hall
14:00 – 15:30 Theme B (Part 1)	AI Engines in Target & Biomarker Discovery	Topic: On federated learning architectures that keep raw data local to safeguard sovereign privacy laws. Topic: Demonstrating machine learning at scale to automate computational target validation. Roundtable Debate: Balancing the sovereignty-access tradeoff, highlighting Local Genomic Data Management and Digital Infrastructure Anchors.
THE FOCUS Deploying decentralized machine learning directly across hospital networks. Accelerating target identification via high-throughput automation without violating state data laws.
15:30 – 16:30	Afternoon Networking & Coffee Break	Exhibition Hall / Poster Viewings & Technical Showcases
16:30 – 17:30 Theme B (Part 2)	Cybersecurity & AI Regulatory Pathways	Topic: Navigating the “Software-as-a-Medical-Device” regulatory landscape for evolving clinical machine learning models. Topic: Cybersecurity strategies and data integrity architectures required to secure decentralized global-scale biobanking. Executive Fireside: Enterprise Commercialization, anchoring data as an asset vs. liability with Regional Venture Capital and Financing Leaders.
THE FOCUS Securing global biorepositories against emerging threats. Clearing regulatory hurdles for continuously evolving clinical algorithms.
17:30	Closing Remarks of Day 1

Day 2: Advanced AI, Population Genomics & The Pan-Arab Powerhouse

Day 2 transitions from computational science into the massive geopolitical, regulatory, and financial frameworks required to build a unified precision medicine ecosystem across the Middle East.

Time & Session	Strategic Focus	Featured Highlights & Local Anchors
08:30 – 10:15 Advanced AI Scientific Session	Generative AI & Transformer Models	Keynote: Industrializing commercial drug discovery pipelines using automated machine learning. Topic: Deploying cloud-native infrastructure for causal disease pathway simulation. Interactive Panel: Transitioning from in-silico AI predictions to in-vitro validated targets.
THE FOCUS Transitioning from passive genomic observations to direct simulation of disease pathways. Industrializing early-stage R&D through high-throughput automation and machine learning foundation models.
10:15 – 10:55	Morning Networking & Coffee Break	Exhibition Hall / Technical Demos
10:55 – 11:45 Master Session 1	The Pan-Arab Powerhouse—Unlocking Scale, Sovereignty, and Market Realities	Strategic Briefing: Global market evaluation and metrics for capturing localized data advantages. High-Level Panel: Mapping existing PAN-Arab capabilities and resolving data fragmentation bottlenecks.
THE FOCUS Analyzing where precision medicine value is being created globally and how the region can secure an edge. Harmonizing regional infrastructure, clinical capabilities, and biobanks into a unified market.
11:45 – 12:30 Master Session 2	The Triad of Scale: Pharma, Ecosystem Enablers, and Sovereign Capital	Topic: Corporate data-access, regulatory predictability, and multi-omic registry mandates required to anchor regional clinical trials. Ecosystem Alignment Panel: Cross-sector integration strategy connecting commercial pipelines with sovereign resources.
THE FOCUS Outlining the exact commercial, data, and clinical infrastructure requirements needed to scale trials in the region. Moving from parallel institutional efforts to a coordinated, outcome-driven alignment of capital and policy.
12:30 – 14:00	Lunch & Networking Break	Main Exhibition Hall & Private Sponsor Lounges
14:00 – 15:30 Population Genomics Focus	Health Sovereignty & Functional Interpretation	Topic: Breakthroughs in complete Telomere-to-Telomere (T2T) assemblies to map highly complex genomic regions. Topic: Resolving clinical data gaps by functional interpretation of unique variants within Middle Eastern cohorts, featuring data-sharing insights from Qatar Genome and Local Biobanking Teams.
THE FOCUS Systematically classifying regional variants that confound Western-centric clinical databases. The vital necessity of domestic cloud compute networks to prevent international biological data monopolies.
15:30 – 16:10	Afternoon Networking & Coffee Break	Exhibition Hall / Technical Demos & Poster Viewings
16:10 – 17:00 The “Unsession” Debate	Is the $1B Blockbuster Drug Model Dead?	The Interactive Controversy: A high-energy, rapid-fire executive debate pitching global pharma volume defenders against precision medicine disruptors.
THE FOCUS Questioning if traditional multi-billion dollar, mass-market drug models can survive the rise of highly custom molecular therapies built for targeted patient niches.

Day 3: Clinical Delivery, Venture Scalability & Systemic Implementation

Day 3 delivers the actionable operational blueprint for systemic change, highlighting commercial scalability, investment trends, and direct pediatric clinical integration.

Time & Session	Strategic Focus	Featured Highlights & Local Anchors
08:30 – 10:15 Theme D (Part 1)	Translating Genomic Discoveries into Daily Pediatric Care	Topic: Operational pathways required to translate rare variant findings into everyday metabolic and pediatric clinical care. Bedside Integration Panel: Reviewing standard reporting tools and clinical decision support systems for frontline physicians, highlighting insights from Sidra Medicine Pediatric Genomic Protocols.
THE FOCUS Overcoming operational barriers to automate genomic variant analysis right at the point-of-care. Transitioning highly specialized genetic discoveries into everyday pediatric workflows and family clinical management.
10:15 – 10:55	Morning Networking & Coffee Break	Exhibition Hall / Final Technical Demos
10:55 – 12:30 Theme D (Part 2)	Healthcare Payer Systems & Provider Alignment	Health Economics Briefing: Financial structures and cost-effectiveness models needed to transform deep genomic sequencing from reactive screening into standard preventive care. Cross-Sector Alignment Panel: Designing modern value-based coding systems between national healthcare systems, private insurance giants, and sovereign funds, featuring Local Academic and Health Economics Experts.
THE FOCUS Overcoming funding gridlocks for deep sequencing panels and individualized genetic therapeutics. Creating sustainable financial frameworks that align the risk profiles of health insurance bodies with multi-omic clinical providers.
12:30 – 14:30	Lunch & Networking Break	Main Dining Hall
14:00 – 15:30 The Investor Pitch	Climate Health & AI for Next-Gen Clinical Trials	Topic: Breakthroughs in complete Telomere-to-Telomere (T2T) assemblies to map highly complex genomic regions. Topic: Resolving clinical data gaps by functional interpretation of unique variants within Middle Eastern cohorts, featuring data-sharing insights from Qatar Genome and Local Biobanking Teams.
THE FOCUS Exploring how environmental data and machine learning architectures open up new investable tech markets. Evaluating startup solutions built to optimize multi-ethnic clinical trial recruitment and digital patient tracking.
15:30 – 17:30 Resolutions & Awards	Regional Resolutions, Closing Debate & PMFG 2026 Awards	Summit Resolution & Call to Action: Final cross-border reflections compiling a regional blueprint for data governance and clinical diagnostics pipelines. The Grand Finale Closing Debate: High-level panel reviewing the next decade of genomic medicine and global health disparities. PMFG 2026 Awards Ceremony: Presentation of abstract awards, young investigator honors, and poster prizes.
THE FOCUS Ecosystem Mobilization: Unifying 3 days of regulatory, scientific, and financial insights into an actionable Pan-Arab strategy roadmap. Honoring Excellence: Celebrating top-tier international and local research discoveries that drive precision medicine forward.
17:30	The Summit 2026 Formal Adjournment	Presented by Sidra Medicine & QPHI Leadership